Identification of mutations in protein kinase CKIIbeta subunit that affect its binding to ribosomal protein L41 and...

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• Protein kinase CKII (casein kinase II) is a crucial enzyme involved in various cellular processes.
• It comprises two catalytic subunits (alpha or alpha') and two regulatory subunits (beta).
• The precise physiological role of the CKIIbeta subunit, particularly its interactions with target proteins, remains largely unknown.

Purpose of the Study:

• To investigate the functional domains of the CKIIbeta subunit involved in protein-protein interactions.
• To identify specific amino acid residues critical for CKIIbeta binding to L41 and for CKIIbeta homodimerization.
• To explore the relationship between CKIIbeta homodimerization and its interaction with other cellular proteins.

Main Methods:

• Utilized the reverse two-hybrid system to screen for point mutants of CKIIbeta.
• Performed sequence analysis to identify mutations affecting L41 binding and homodimerization.
• Tested the interaction of isolated CKIIbeta mutants with known binding partners like L5, topoisomerase IIbeta, and CKBBP1/SAG.

Main Results:

• Identified Asp-26, Met-52, and Met-78 as critical residues for L41 binding in CKIIbeta.
• Determined that Asn-67 (and/or Lys-139) and Met-52 are important for CKIIbeta homodimerization.
• Demonstrated that certain CKIIbeta mutants (R75, R83) bind to L5, topoisomerase IIbeta, and CKBBP1/SAG independently of homodimerization.

Conclusions:

• CKIIbeta homodimerization is not essential for its interaction with all target proteins.
• Specific point mutations in CKIIbeta disrupt L41 binding and/or homodimerization, providing tools to study its function.
• These findings offer insights into the complex regulatory mechanisms and physiological roles of CKIIbeta.